What NAD infusion studies actually measure
Blood chemistry can establish exposure. It takes a different study to establish a meaningful benefit.
Clear explanations of what studies found, what they did not establish and why the distinction matters.
Blood chemistry can establish exposure. It takes a different study to establish a meaningful benefit.
Study populations and endpoints explain more than a simple precursor leaderboard.
A responsive biomarker is useful evidence, but it is not a validated promise of benefit.
Everyday tiredness, drowsiness and a diagnosed fatigue condition are different research questions.
Ventilatory thresholds, peak capacity and daily function tell different stories.
Different molecules and routes require separate evidence, even when the marketing uses the same initials.
A small trial with few reported events cannot establish safety for every product or long-term user.
Analytical measurement and evidence that testing improves a decision are different standards.